SANTORO, ARMANDO
 Distribuzione geografica
Continente #
NA - Nord America 575
AS - Asia 441
EU - Europa 136
Continente sconosciuto - Info sul continente non disponibili 43
SA - Sud America 21
AF - Africa 10
Totale 1.226
Nazione #
US - Stati Uniti d'America 547
SG - Singapore 193
VN - Vietnam 100
CN - Cina 87
IT - Italia 40
FR - Francia 39
BD - Bangladesh 30
SE - Svezia 28
BR - Brasile 14
CA - Canada 11
HK - Hong Kong 9
DE - Germania 8
IE - Irlanda 5
CR - Costa Rica 4
GB - Regno Unito 4
TR - Turchia 4
MX - Messico 3
PH - Filippine 3
PL - Polonia 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
EC - Ecuador 2
ES - Italia 2
FI - Finlandia 2
ID - Indonesia 2
IN - India 2
IQ - Iraq 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
PK - Pakistan 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
BB - Barbados 1
BE - Belgio 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
KY - Cayman, isole 1
MA - Marocco 1
MF - Saint Martin 1
MU - Mauritius 1
NL - Olanda 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
VE - Venezuela 1
Totale 1.183
Città #
San Jose 108
Singapore 95
Council Bluffs 86
Ashburn 65
Lauterbourg 35
Ho Chi Minh City 28
Santa Clara 27
Hanoi 26
Boardman 17
Phoenix 11
New York 9
Da Nang 8
Beijing 6
Parma 6
Buffalo 5
Chandler 5
Dublin 5
Bologna 4
Chicago 4
Dallas 4
Los Angeles 4
Milan 4
Nashua 4
Orlando 4
Alexandria 3
Charleston 3
Denver 3
Genoa 3
Hong Kong 3
Johannesburg 3
Munich 3
Nuremberg 3
Rome 3
San Antonio 3
San José 3
Thomasville 3
Atlanta 2
Bakersfield 2
Baku 2
Blanchard 2
Can Tho 2
Champaign 2
Copenhagen 2
Frankfurt am Main 2
Guangzhou 2
Haiphong 2
Houston 2
Joliet 2
Lewisville 2
Montreal 2
Nanchang 2
Nashville 2
Norwalk 2
Pensacola 2
Queens 2
Querétaro 2
Sacramento 2
Sioux Falls 2
Tallahassee 2
Tashkent 2
Toms River 2
Tân Tiến 2
Upper Marlboro 2
Warsaw 2
Abbeville 1
Abidjan 1
Adana 1
Adrano 1
Alessandria 1
Alliston 1
Ambato 1
Ankara 1
Ann Arbor 1
Augusta 1
Baghdad 1
Baltimore 1
Barakaldo 1
Bari 1
Basra 1
Beau Bassin-Rose Hill 1
Beauchamps 1
Beirut 1
Bekasi 1
Bento Gonçalves 1
Berwyn 1
Bitonto 1
Biyala 1
Bloomington 1
Blue Springs 1
Boston 1
Bowie 1
Boynton Beach 1
Brasília 1
Brescia 1
Bridgetown 1
Bronxville 1
Burnaby 1
Bình Phước 1
Bến Tre 1
Cabo Frio 1
Totale 698
Nome #
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer 126
Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas 53
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications 46
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection 45
Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma 36
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity? 36
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? 35
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma 33
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study 32
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study 32
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study 31
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 31
Tivantinib for Second-line Treatment of Advanced MET-High Hepatocellular Carcinoma: A Phase 3, Randomized, Placebo-Controlled Study (METIV-HCC) 31
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 30
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors 29
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma 29
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment 28
Biomarkers in Hepatocellular Carcinoma-Letter 28
Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial 28
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer 26
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 26
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 26
COVID-19 and liver cancer clinical trials: not everything is lost 25
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? 25
Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer 25
Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection 24
Reply to Y. Pointreau et al 22
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study 21
Prognostic value of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: an exploratory analysis from the second-line ARQ 197-215 study 21
Cabozantinib for the treatment of hepatocellular carcinoma 21
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study 21
Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study 20
Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND) 20
Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications 19
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomized, placebo-controlled phase 2 study 18
Regorafenib for the treatment of unresectable hepatocellular carcinoma 18
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 18
Tivantinib for hepatocellular carcinoma 18
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma 17
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 15
Sorafenib in hepatitis C-virus negative patients with hepatocellular carcinoma: don’t throw the baby out with the bathwater 15
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer 14
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma 12
Totale 1.226
Categoria #
all - tutte 5.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.127


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 1 0 0 0 1
2022/202318 3 3 1 1 1 2 0 1 6 0 0 0
2023/20247 0 2 0 0 1 2 0 1 0 0 0 1
2024/202523 0 1 1 3 2 3 0 0 4 1 3 5
2025/2026758 5 4 5 3 104 115 138 83 122 109 47 23
2026/2027405 129 97 106 73 0 0 0 0 0 0 0 0
Totale 1.226